Dehydrocostuslactone, a sesquiterpene lactone activates wild-type and ΔF508 mutant CFTR chloride channel.

about

Dehydrocostuslactone, a sesquiterpene lactone activates wild-type and ΔF508 mutant CFTR chloride channel.

Item

http://www.wikidata.org/entity/Q44112526

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Dehydrocostuslactone, a sesqui ...... mutant CFTR chloride channel.

@en

Dehydrocostuslactone, a sesqui ...... mutant CFTR chloride channel.

@nl

type

Item

label

Dehydrocostuslactone, a sesqui ...... mutant CFTR chloride channel.

@en

Dehydrocostuslactone, a sesqui ...... mutant CFTR chloride channel.

@nl

prefLabel

Dehydrocostuslactone, a sesqui ...... mutant CFTR chloride channel.

@en

Dehydrocostuslactone, a sesqui ...... mutant CFTR chloride channel.

@nl

P1476

Dehydrocostuslactone, a sesqui ...... mutant CFTR chloride channel.

@en

P2093

Bo Yu

http://www.w3.org/2001/XMLSchema#string

Hong Yang

http://www.w3.org/2001/XMLSchema#string

Jian Luan

http://www.w3.org/2001/XMLSchema#string

Shuang Yang

http://www.w3.org/2001/XMLSchema#string

Xin Liu

http://www.w3.org/2001/XMLSchema#string

Xue Wang

http://www.w3.org/2001/XMLSchema#string

Yao-Fang Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

Identification of the cystic fibrosis gene: genetic analysis

CFTR chloride channel as a molecular target of anthraquinone compounds in herbal laxatives

Molecular pharmacology of the CFTR Cl- channel.

Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening.

Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3β and mTOR signaling pathways

Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure-activity analysis, and in vivo efficacy.

CFTR pharmacology and its role in intestinal fluid secretion.

Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2

P304

855-866

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10286020.2013.804814

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23799322

http://www.w3.org/2001/XMLSchema#string